Restrictive cardiomyopathy

Article written and reviewed by Dr Luca Moretti

Restrictive cardiomyopathy is a myocardial phenotype in which one or both ventricles cannot accommodate venous return without a marked increase in diastolic pressures. Ventricular volumes are normal or reduced, the atria tend to dilate, and wall thickness may be normal or increased depending on the cause. Filling dysfunction dominates the initial presentation, whereas ejection fraction may remain formally preserved despite reduced cardiac output and severe heart failure.

Documenting a restrictive mitral inflow pattern is not sufficient to establish the diagnosis. That pattern is influenced by circulating volume, heart rate, age and atrial pressure and also occurs in advanced stages of dilated or hypertrophic cardiomyopathy. The clinical definition requires restriction to represent the dominant structural behavior of nondilated ventricles, after considering pericardial constriction, valvular disease and hemodynamic overload. This phenotypic distinction prevents a single Doppler index from being turned into a disease.

The category includes primary genetic forms, infiltrative or storage diseases, endomyocardial disorders, consequences of radiation and systemic conditions. Some are treatable with causal therapies, whereas others mainly require heart failure control and transplantation planning. For this reason, the complete diagnosis should express at least the phenotype, probable etiology, hemodynamic severity, rhythm, function of both ventricles and extracardiac involvement. The multidimensional description guides decisions that the label RCM alone cannot encompass.

Epidemiological data are incomplete because classifications, access to genetics and the ability to recognize amyloidosis have changed over time. The primary form is the least common of the classic cardiomyopathies and accounts for approximately 2-5% of pediatric cases, whereas in adults many secondary restrictive forms are coded under the specific etiology. The apparent prevalence therefore depends on the population and taxonomy and does not directly measure the clinical burden of restrictive physiology.

Diastolic mechanics, pressures and low cardiac output

Ventricular relaxation is an active process that consumes energy to reuptake calcium and detach actin-myosin cross-bridges. In sarcomeric forms, greater calcium sensitivity or altered myofilament kinetics prolong diastolic tension; in infiltrative forms, extracellular material separates and compresses cardiomyocytes; in endomyocardial forms, a fibrotic surface geometrically limits the cavity. Different mechanisms converge on ventricular stiffness, while retaining different diagnostic clues and therapeutic possibilities.

The diastolic pressure-volume relationship becomes steep: adding even a few milliliters requires a large pressure increase. At rest, compensation may maintain acceptable output through high atrial pressures, but during exercise the ventricle cannot adequately increase stroke volume. If heart rate rises too much, diastole shortens; if it is slowed excessively, cardiac output may decrease because stroke volume is relatively fixed. This limited cardiac reserve explains dyspnea and fatigue disproportionate to ejection fraction.

In overt stages, the initial atrioventricular gradient generates rapid filling, followed by abrupt deceleration when the ventricle reaches its distensibility limit. Elevated end-diastolic pressure reduces the effective contribution of atrial contraction, although sinus rhythm remains important for synchronizing filling. Persistent elevation of left atrial pressure causes pulmonary congestion and vascular remodeling; elevation of right atrial pressure causes systemic congestion. Backward transmission links a microscopic property of the wall to multiorgan failure.

The atria enlarge, develop fibrosis and lose reservoir, conduit and pump function. Atrial fibrillation and flutter become frequent, functional mitral and tricuspid regurgitation may progress, and stasis promotes thrombus formation. Even in sinus rhythm, severe atrial myopathy may reduce emptying velocity and maintain an embolic risk that is not perfectly represented by conventional scores. Atrial disease is therefore a prognostic and therapeutic component, not a benign adaptation.

The right ventricle is affected both by its own stiffness and by increased pulmonary afterload. As pulmonary pressure rises, the septum shifts, tricuspid regurgitation worsens and left-sided output falls further. Renal and hepatic congestion hinder the response to diuretics, alter pharmacokinetics and make any procedure riskier. The cardiorenal-hepatic circuit may become the main driver of deterioration before a marked reduction in left ventricular systolic function occurs.

Genetic, infiltrative and endomyocardial causes

Isolated familial forms share part of their genetic architecture with hypertrophic and dilated cardiomyopathy. TNNI3 variants are historically associated with severe restrictive phenotypes, often with early onset; TNNT2, MYH7, ACTC1, MYL2 and MYL3 have also been described. The overlap arises because the same contractile apparatus can produce hypertrophy, stiffness or dilation depending on the variant and modifiers. The sarcomeric continuum makes it inadequate to associate each gene with a single morphology.

FLNC encodes filamin C, a protein that links the sarcomere, Z-disc and membrane, whereas DES encodes the intermediate filament desmin. Variants in these genes may associate restriction with arrhythmias, conduction disorders and skeletal myopathy; expressivity may vary within the same family. FHL1, BAG3 and other genes have been reported in specific contexts, but validity and mechanism must be verified before clinical use. Panel selection should prioritize genes with a convincing causal relationship.

Amyloidosis deposits extracellular fibrils and is the most relevant infiltrative cause in adults. AL and ATTR forms differ in precursor, urgency and treatment; a monoclonal gammopathy does not prove AL, and a positive scintigraphy does not permit an ATTR diagnosis if testing for a monoclonal protein is abnormal. Sarcoidosis, hemochromatosis and storage diseases may mimic restriction, but granulomas, iron or lysosomal material require their own pathways. Typing the deposit always precedes specific therapy.

Endomyocardial fibrosis mainly involves the apices and inflow tracts, with thrombi, obliteration and retraction of the valvular apparatus. In hypereosinophilic syndrome, injury may progress from acute necrosis to a thrombotic phase and finally a fibrotic phase, whereas in tropical regions endomyocardial fibrosis may present without active eosinophilia. Magnetic resonance and echocardiography show the distribution, but the biological phase determines whether therapy should target inflammation, thrombosis or mechanical consequences.

Thoracic radiotherapy may cause myocardial and pericardial fibrosis, coronary artery disease, valvular disease and conduction disorders years later. Systemic sclerosis and other immune-mediated diseases may produce microvascular disease and fibrosis, whereas drugs or toxins have rarer associations. In these settings, a composite etiology is more realistic than a single explanation and changes the estimated benefit of pericardiectomy, revascularization or immunomodulatory therapy.

Clinical presentation and etiologic clues

Exertional dyspnea is often the first symptom and reflects increased pulmonary pressures and inability to augment cardiac output. With progression, orthopnea, edema, ascites, early satiety and weight loss develop; right-sided manifestations may predominate and mimic cirrhosis or venous disease. Congestion with preserved ejection fraction should prompt a search for restriction when the walls, atria and ECG are not explained by hypertension or valvular disease.

Palpitations, presyncope and syncope require rhythm documentation but may also result from low output or hypotension. Conduction disorders suggest amyloidosis, sarcoidosis or desminopathy; atrioventricular block in a young person with muscle weakness radically changes the genetic investigation. Ventricular arrhythmias are not uniformly frequent in all RCMs, and the electrical profile should be attributed to the cause rather than to the phenotype in the abstract.

Bilateral carpal tunnel syndrome, lumbar spinal stenosis, biceps tendon rupture and sensory-autonomic neuropathy point toward ATTR, whereas proteinuria, macroglossia, periorbital purpura and weight loss strengthen suspicion of AL. Eosinophilia, asthma and vasculitic manifestations point toward eosinophilic disease; lung disease, lymphadenopathy or skin lesions may indicate sarcoidosis. Extracardiac clues have diagnostic value when combined, not when treated as absolute criteria.

In children, the presentation includes poor growth, tachypnea, feeding fatigue, abdominal pain due to congestion and syncope. Atrial size may be extreme relative to normal ventricles, and pulmonary pressure may rise rapidly. Normal systolic function does not provide adequate reassurance about the course; pediatric severity is measured through symptoms, hemodynamics and trajectory, not merely through ejection fraction.

The physical examination assesses blood pressure, signs of low output, apical impulse, heart sounds, murmurs, jugular venous pressure and inspiratory response, as well as the liver, ascites and edema. A third heart sound may be present, whereas a fourth heart sound disappears with atrial fibrillation. Marked pulsus paradoxus points more toward tamponade or specific respiratory conditions than toward pure RCM. Integrated clinical examination establishes severity and probability but cannot by itself distinguish all causes.

From phenotype confirmation to etiologic characterization

The ECG assesses rhythm, conduction, voltages, P waves and pseudoinfarction patterns. Echocardiography documents dilated atria, nondilated ventricles, wall thickness, function, valves, pulmonary pressure and the vena cava, integrating mitral, tricuspid, pulmonary venous and hepatic venous flows with tissue Doppler. A high E/A ratio and short deceleration time depend on high atrial pressure but may pseudonormalize after diuresis. Load-dependent physiology requires preservation of the clinical context of the examination.

Septal and lateral e' velocities are generally reduced in myocardial disease, whereas in constriction medial e' velocity may be preserved or increased and exceed lateral e', a phenomenon called annulus reversus. Longitudinal strain helps identify subclinical injury and suggestive patterns but does not replace etiologic characterization. Tissue Doppler works best as part of an algorithm that includes respiration, septal motion and hepatic veins.

Magnetic resonance quantifies chamber size and cardiac output and shows fibrosis or infiltration through LGE, T1 and ECV. In amyloidosis, extracellular expansion may be diffuse and make myocardial nulling difficult, whereas the absence of LGE does not exclude an early stage. In iron overload, T2* is the specific measure, not wall thickness alone. Multiparametric characterization transforms imaging from a morphological description into an etiologic tool.

Laboratory testing includes blood count, electrolytes, renal and liver function, troponin and natriuretic peptides, followed by targeted tests. When amyloidosis is possible, serum and urine immunofixation and free light chains must be performed together; electrophoresis alone does not have sufficient sensitivity. Iron and transferrin saturation, eosinophils, inflammatory markers and metabolic tests follow the clinical context. Complete monoclonal protein assessment is a priority because AL cannot wait for a slow diagnostic pathway.

Genetic testing is indicated in familial forms and primary RCM, with counseling before and after testing. A pathogenic variant establishes a hereditary etiology and enables cascade screening; a variant of uncertain significance should not be promoted to a diagnosis on the basis of rarity. Trio analysis may identify de novo variants in pediatric cases. Familial segregation adds evidence but should not be interpreted without considering penetrance and phenocopies.

Endomyocardial biopsy is appropriate when a specific histological diagnosis can change treatment and noninvasive tests are inconclusive. Congo red identifies amyloid, and mass spectrometry or expert immunohistochemistry types the precursor; stains and microscopy search for iron, storage material or endomyocardial disease. Sampling and focal distribution limit sensitivity. A question-driven biopsy is different from a procedure performed merely because the diagnosis is difficult.

Myocardial restriction or pericardial constriction

Constrictive pericarditis limits cardiac expansion from outside and dissociates intracardiac pressures from intrathoracic pressure changes; RCM limits filling within the wall itself. Both cause high venous pressures, a dip-and-plateau pattern and congestion, but only constriction may improve with pericardiectomy. The anatomical boundary is therefore one of the most important distinctions in all of diastolic cardiology.

In constriction, inspiration increases right-sided venous return without normal transmission to the left heart, shifting the septum and reducing left-sided filling; this produces septal bounce, respiratory variation in flows and expiratory diastolic flow reversal in the hepatic veins. In restriction, pressures in the two ventricles change more concordantly with respiration and e' velocities are reduced. Ventricular interdependence is more informative than the mere presence of a thickened pericardium.

CT and magnetic resonance identify pericardial thickening, calcification, adhesions and inflammation, but constriction may exist with normal thickness and thickening may not be hemodynamically significant. Magnetic resonance also evaluates septal motion in real time and myocardial tissue, revealing possible mixed disease. Anatomical-functional imaging avoids both false negatives and causal attributions based on incidental findings.

If uncertainty persists, simultaneous ventricular catheters analyze beat-to-beat pressures during spontaneous respiration. In constriction, right ventricular systolic pressure rises while left ventricular systolic pressure falls during inspiration, generating discordance; in restriction they change in the same direction. Deep sedation, hypovolemia and interpretation of static tracings alone may obscure the result. Invasive respiratory dynamics requires expert technique and interpretation.

A history of cardiac surgery, radiotherapy, tuberculosis or pericarditis increases the probability of constriction but does not exclude concomitant cardiomyopathy. After radiation, for example, the pericardium may be only one component of a disease that includes myocardium, valves and coronary arteries, reducing surgical benefit. Pre-test probability should be updated by each modality, not replaced by a single striking image.

Treatment of heart failure and the underlying etiology

Diuretics reduce atrial pressures, edema and ascites but must preserve sufficient preload to maintain cardiac output. The dose is adjusted according to weight, symptoms, blood pressure, renal function, sodium and urinary response; resistance and intestinal congestion may require sequential combination therapy or intravenous treatment. Controlled decongestion aims for euvolemia without interpreting an isolated creatinine increase as an automatic obligation to leave the patient congested.

ACE inhibitors, angiotensin receptor blockers, ARNI, beta-blockers, mineralocorticoid receptor antagonists and SGLT2 inhibitors have strong indications in specific heart failure syndromes, but uniform evidence does not exist for all RCMs. Low blood pressure, dysautonomia and fixed output often limit titration; when true reduced ejection fraction develops, heart failure guidelines become more applicable. Therapeutic transferability depends on the phenotype and cause, not on the generic presence of dyspnea.

Atrial fibrillation is managed with attention to heart rate tolerance, the likelihood of maintaining rhythm and thrombotic risk. Digoxin and nondihydropyridine calcium-channel blockers require caution in some infiltrative forms and in systolic dysfunction; amiodarone is often used but carries extracardiac toxicity. The rhythm-output balance should be reassessed after every change because numerically satisfactory control may worsen functional capacity.

Pacemakers, ICDs and cardiac resynchronization therapy follow indications for block, arrhythmias and dyssynchrony, integrated with etiology and prognosis. An ICD does not correct mechanical failure, pulseless electrical activity or terminal bradyarrhythmia and should not be proposed solely on the basis of the RCM label. The device indication requires a preventable mechanism of death and an expected benefit compatible with the systemic disease.

Specific therapy takes priority when it exists. The plasma cell clone in AL must be suppressed rapidly; ATTR requires drugs that stabilize or reduce transthyretin according to indications; iron, granulomas or eosinophils are treated with their own strategies. An incorrect diagnosis may be dangerous, such as attributing bone-tracer uptake to ATTR in the presence of a monoclonal component without tissue confirmation. Etiologic precision is part of therapeutic safety.

Prognosis, transplantation and surveillance

Functional class, hospitalizations, blood pressure, natriuretic peptides, troponin, renal and liver function, pulmonary pressure, cardiac output and right ventricular function describe severity. Amyloidosis-specific scores should not be applied to sarcomeric forms and vice versa. Etiology-specific prognosis is more accurate than an average across diseases with radically different natural histories and treatments.

In primary pediatric forms, the risk of death or transplantation is high and may increase with associated hypertrophy, ischemia, syncope or pulmonary pressure. In adults, progression is variable, but refractory ascites, hyponatremia, low output and repeated hospitalizations indicate an advanced stage. The serial trajectory matters more than a single measurement because it shows the rate at which reserve is being lost.

Transplantation is assessed before irreversible pulmonary vascular resistance or organ injury excludes candidacy. In AL, the clone must be controlled and systemic involvement estimated; in some hereditary ATTR forms the strategy may include hepatic considerations, now modified by the availability of pharmacological therapies. Multidisciplinary selection balances cardiac benefit, recurrence of the precursor and extracardiac prognosis.

Small cavities, right-sided failure and filling physiology make mechanical ventricular support more complex than in dilation. Cannula positioning, suction risk, arrhythmias and the need for biventricular support limit applicability, although they do not make it impossible in selected cases. The bridging strategy should be discussed early at centers with specific expertise, not improvised during multiorgan shock.

Surveillance includes symptoms, volume status, ECG, rhythm monitoring, echocardiography and biomarkers at tailored intervals. In at-risk relatives it adds cascade genetic testing and longitudinal assessments; in patients with a systemic cause it integrates hematologic, neurologic, renal or metabolic parameters. Continuous care keeps symptom control, disease modification and timely access to advanced options aligned.

Exercise, pregnancy and noncardiac procedures

Cardiopulmonary exercise testing measures peak oxygen uptake, ventilatory slope, oxygen pulse and blood pressure response and may reveal an inability to increase cardiac output that is not evident at rest. Low values, however, may also result from anemia, deconditioning, pulmonary disease and muscle disease, so the tracing is interpreted in context. Exercise physiology contributes to prognosis, activity prescription and the timing of advanced therapies.

Light or moderate aerobic activity is often preferable to sedentary behavior, but intensity, duration and environment depend on pulmonary pressure, arrhythmias and cardiac output. Warm-up, cool-down, controlled hydration and recognition of dizziness or unusual dyspnea increase safety. Functional prescription does not use a single prohibition for all causes: an arrhythmic sarcomeric form, amyloidosis and stable RCM do not share the same risk.

Pregnancy increases plasma volume, heart rate and cardiac output, and the postpartum period produces rapid fluid shifts. A woman with high pressures, right ventricular dysfunction or arrhythmias may decompensate even if ejection fraction is preserved; medications and anticoagulation require review before conception. Preconception assessment brings together cardiology and high-risk obstetrics and discusses maternal risk, heredity and the delivery plan without reducing the choice to an abstract yes or no.

Anesthesia and noncardiac surgery alter preload, vascular resistance and rhythm and may be poorly tolerated. Preoperative assessment defines euvolemia, pulmonary pressure, arrhythmias, device status and monitoring needs, avoiding excessive fasting or indiscriminate fluid boluses. Perioperative stability depends on maintaining rhythm, blood pressure and venous return more than on a normal ejection fraction reported on the examination.

Comorbidities and organ injury as part of cardiomyopathy

Renal dysfunction may result from low output, venous congestion, diuretics or systemic disease, and each mechanism requires a different response. Automatically reducing the diuretic because of a modest creatinine increase sometimes leaves venous pressure that continues to injure the kidney; persisting with decongestion in an already hypovolemic patient produces the opposite problem. A cardiorenal assessment integrates examination, sodium, blood pressure, urine and trends rather than reacting to a single value.

Congestive liver disease increases bilirubin and alkaline phosphatase and may progress to fibrosis, malnutrition and coagulopathy. Cardiac ascites often has a high protein content, but a primary hepatic or peritoneal cause may coexist and requires appropriate analysis. Hepatic congestion is an indicator of right-sided pressure and disease duration and influences transplant candidacy and procedural risk.

Anemia, iron deficiency, sleep apnea, pulmonary disease and obesity further reduce exercise capacity. Correcting them may improve symptoms without altering ventricular stiffness and allows a more accurate assessment of residual cardiac reserve. The extracardiac component of limitation does not diminish the importance of RCM but identifies interventions with a favorable benefit-risk ratio.

Frailty includes strength, speed, nutrition and cognition and is not synonymous with age. It may improve with decongestion and rehabilitation or reflect advanced systemic disease; for this reason, it should be measured serially before procedures are excluded. Global reserve complements hemodynamic variables and helps distinguish modifiable risk from true futility.

During follow-up, an effective decision links a problem to an outcome measure: less congestion to weight and renal function, rhythm control to symptoms and cardiac output, causal therapy to specific biomarkers, and advanced assessment to pressures and organ function. Goal-directed care makes transparent why a drug is continued, reduced or replaced and limits the accumulation of prescriptions that are no longer useful.